The aim of the present study was to assess the prevalence of the IDH1105GGT SNP in a cohort of Italian patients with brain tumors classified according to 2016 WHO criteria, and investigate its association with clinicopathologic features and IDH tumor missense mutations. The gene discussed is IDH1; the disease is brain neoplasm.